TRPM7 and neuroblastoma: Combined with our in vitro and in vivo data, these data support the notion that shRNA-mediated knockdown of TRPM7 impairs the malignant potential of human SH-SY5Y neuroblastoma cells at the gene expression level, by reducing a progenitor-like state.